• Direct Cost Of Hiv/Aids In Turkey

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis Of Laparoscopic Surgery For Presumed Leiomyomas

    Nov 1, 2016, 00:00

  • Atrial Fibrillation- Evidence Generation and Practice Improvement. Real World Evidence From Italian Administrative Databases

    Nov 1, 2016, 00:00

  • Economic Resources Optimisation In The Hcv Setting- The Role Of The Daas

    Nov 1, 2016, 00:00

  • Cost Minimisation Analysis- When And Where? A Review Of Hta Guidance On Cost Minimisation Analysis

    Nov 1, 2016, 00:00

  • The Impact of Duration on EQ‐5D‐5l Value Sets Derived from a Discrete Choice Experiment

    Nov 1, 2016, 00:00

  • Development of a Global Model for the Economic Evaluation of Personalized Medicine for the Treatment of Prostate Cancer

    Nov 1, 2016, 00:00

  • Real-World Outcomes of Ipilimumab in Patients with Advanced Melanoma in The Netherlands

    Nov 1, 2016, 00:00

  • Brain Metastasis Prediction in Breast Cancer Women- Usefulness of Mathematical Modeling of Montecarlo

    Nov 1, 2016, 00:00

  • Temperature, Real Time, on Site, Potency Monitoring Studies of Different Brands of Cephalexin Tablets Stored in Hospital and Community Pharmacies in Different Part of Kerala

    Nov 1, 2016, 00:00

  • The Study of the Incidence, Etiology and Risk Factors for Constipation within Cancer Palliative Care Patients

    Nov 1, 2016, 00:00

  • Costs and Clinical Outcomes in The Management of Metastatic Castration-Resistant Prostate Cancer in Greece

    Nov 1, 2016, 00:00

  • Characteristics of Patients with Type 2 Diabetes Mellitus Initiated on Basal Insulin Regimens- Retrospective Analysis of Electronic Health Record Data

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Using Pazopanib-Everolimus in First and Second Line of Treatment, In Patients with Metastatic Renal Cell Carcinoma

    Nov 1, 2016, 00:00

  • Cost Implications of Adapting The Investigation And Diagnosis Pathway of Infertilty Patients In A Uk Nhs Setting

    Nov 1, 2016, 00:00

  • Economic Burden of Medical Transports In France over The Year 2014

    Nov 1, 2016, 00:00

  • Glatiramer Acetate (Ga) Is Cost-Effective Compared To Interferons And Best Supportive Care (Bsc) For Relapsing Remitting Multiple Sclerosis (Rrms) In The Uk

    Nov 1, 2016, 00:00

  • An Observational Study on Risk Factors and Clinical Presentation S In Stroke Patients

    Nov 1, 2016, 00:00

  • Content Validation of the Pulmonary Arterial Hypertension Symptoms and Impact (PAH-SYMPACT®) Questionnaire

    Nov 1, 2016, 00:00

  • Types of Risk-Sharing Schemes Proposed in Reimbursement Application Received by Aotmit in 2015

    Nov 1, 2016, 00:00

  • Biosimilar Infliximab In The 37 Public Hospitals Of Paris- Meeting The Challenge Of Substitution

    Nov 1, 2016, 00:00

  • Drug Utilization Evaluation of Amoxicillin-Clavulanic Acid in Csom Patients in a South Indian Hospital- A Retrospective Analysis

    Nov 1, 2016, 00:00

  • Association Between Comorbidities and Maintenance Medication Persistence Among Medicaid Beneficiaries with Newly-Diagnosed Copd

    Nov 1, 2016, 00:00

  • The Impact on Long-Term Targeted Therapy with Omalizumab on The Quality of Life According To Registry of Children with Uncontrolled Severe Persistent Asthma (Russian Experience)

    Nov 1, 2016, 00:00

  • The Challenge of Critical Mass To Be Overcome By International HTA Networks

    Nov 1, 2016, 00:00

  • Network Meta-Analysis of Randomized Trials to Compare the Efficacy of Nsaids, Statins and Vitamins in Alzheimer's Disease

    Nov 1, 2016, 00:00

  • Defining the Value- Do the New Oncology Frameworks in the Us Aim at Objective Valuation? – A Case Study in Multiple Myeloma

    Nov 1, 2016, 00:00

  • Health Related Quality of Life Among Patients with Heart Failure in South Korea

    Nov 1, 2016, 00:00

  • Hospital Admissions and Costs of Crohn's Disease in New Zealand and the Impact of Adalimumab

    Nov 1, 2016, 00:00

  • Economic Impact Of Adverse Drug Reactions- A Pubmed Based Study

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis Of Alemtuzumab Versus Natalizumab For The Treatment Of Relapsing-Remitting Multiple Sclerosis- Us Payer Perspective

    Nov 1, 2016, 00:00

  • Patient Preferences In The Treatment of Neovascular Age-Related Macular Degeneration- A Discrete Choice Experiment

    Nov 1, 2016, 00:00

  • Market Uptake Of Pharmaceutical Innovations In Germany - Regulatory Approaches And Its Consequences

    Nov 1, 2016, 00:00

  • Cost Analysis Of Raltegravir Versus Atazanavir/R Or Darunavir/R For Treatment-Naive Adults With Hiv-1 Infection In Spain

    Nov 1, 2016, 00:00

  • Cardiovascular Events of Patients Presenting with Peripheral Artery Disease (PAD)- An Epidemiological Analysis Using a Claims Database in France

    Nov 1, 2016, 00:00

  • A Cost of Illness Analysis of Pulmonary Arterial Hypertension in Greece

    Nov 1, 2016, 00:00

  • Changing Patterns of Medication Use at the End of Life in the Elderly

    Nov 1, 2016, 00:00

  • Clinical Impact of Antimicrobial Impregnated Catheters For Reduction of Infection In Cerebrospinal Fluid Diversion Procedures

    Nov 1, 2016, 00:00

  • Trends in Japanese Clinical Trial Registration from 2005 to 2014

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Lorcaserin In The Treatment of Obesity

    Nov 1, 2016, 00:00

  • Achieving Optimal Fit-To-Survival Data Using Cubic Spline Models- A Case-Study Comparing The Fit of Standard and Cubic Spline Models to Survival Data from the Icon6 Study

    Nov 1, 2016, 00:00

  • UK Cost-Effectiveness Analysis for Management of CMV Disease in Patients Post Allogeneic Stem Cell Transplantation with a Novel Adoptive T Cell Therapy

    Nov 1, 2016, 00:00

  • Modeling the Cost-Effectiveness of Statin Therapy in Rheumatoid Arthritis A Markov-Cycle Evaluation From the National Data Bank for Rheumatic Diseases

    Nov 1, 2016, 00:00

  • Prioritizing Medication Problems in Care of People with Cancer and Solutions For These- A Prioritize Study

    Nov 1, 2016, 00:00

  • Incremental Cost-Effectiveness of Algorithm-Driven Genetic Testing Versus no Testing for Maturity Onset Diabetes of the Young (Mody) in Singapore

    Nov 1, 2016, 00:00

  • Economic and Humanistic Impact Assumptions for Hypoglycemic Events- Implications for Cost-Effectiveness Analyses in Insulin-Treated Diabetes

    Nov 1, 2016, 00:00

  • Paucity of Clinical Data in Oncology HTA Submissions- Key Learnings from Recent Case Studies

    Nov 1, 2016, 00:00

  • What EU Mean to the MHRA! Potential Impact of ‘Brexit’ on Pharmaceutical Regulation in the UK

    Nov 1, 2016, 00:00

  • Psychometric Properties Of The Finnish Version Of The Lower Extremity Functional Scale Among Foot And Ankle Patients

    Nov 1, 2016, 00:00

  • Assessing Health-State Utility Values in Australian People with Multiple Sclerosis

    Nov 1, 2016, 00:00

  • Implementation of One Stop Diagnosis In Patients with Thyroid Nodules- Impact on Cost And Surgery

    Nov 1, 2016, 00:00

  • Estimating the Economic Burden of Treatment Resistant Depression in Taiwan using the NHIRD

    Nov 1, 2016, 00:00

  • Assessing The Clinical And Economic Burden of Prostate Cancer in The United States Veteran Population

    Nov 1, 2016, 00:00

  • The Patient-Risk of Hypoglycaemia As A Function of Pharmacological Treatments. A Retrospective Analysis on Database Hypothesis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of a Combination of Renin-Angiotensin System Inhibitors (Ras)/Calcium Channel Blockers (Ccb) or Ras Monotherapy to Retard Progression of Kidney Disease in Malaysia

    Nov 1, 2016, 00:00

  • Complete Remission and Survival Ratio Comparison Between Transplant and Non-Transplant AML Patients Receiving Standard Regimen in a Malaysian Hospital

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Fidaxomicin Versus Oral Vancomycin for the Treatment of Clostridium Difficile Infection in Egypt

    Nov 1, 2016, 00:00

  • Using Acoustic Simulations of Hearing Loss to Describe Health States- Are they Feasible and Reliable to use?

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Serelaxin in Treatment of Patients with Acute Decompensated Heart Failure

    Nov 1, 2016, 00:00

  • Study of Contrast Induced Nephropathy in Patients Undergoing Cardiac Catheterization- Upper Egypt Experience

    Nov 1, 2016, 00:00

  • Treatment Rates in Patients with HER2+ Metastatic Breast Cancer and the Factors Influencing Treatment Decision

    Nov 1, 2016, 00:00

  • The Evolution And Comparison Of Hta Assesment Organisations In Selected European Countries

    Nov 1, 2016, 00:00

  • Copyright/Subscription

    Nov 1, 2016, 00:00

  • Long-Term Healthcare Costs of Patients with Symptomatic Peripheral Artery Disease with and without a History of Atherosclerotic Disease- Results from a Swedish Nationwide Study

    Nov 1, 2016, 00:00

  • Personalized Mammography Screening and Screening Adherence - A Simulation of Cost-Effectiveness

    Nov 1, 2016, 00:00

  • Projected Long-Term Outcomes in Patients with Type 1 Diabetes Mellitus Treated with Faster-Acting Insulin Aspart Versus Conventional Insulin Aspart in the UK Setting

    Nov 1, 2016, 00:00

  • Generating Real World Eviden Guidance On The Design And Conduct Of Retrospective Chart Review Studies

    Nov 1, 2016, 00:00

  • Medical Costs Attributable To Obesity In Working Osteo-Arthritis Patients In The US

    Nov 1, 2016, 00:00

  • Adjusting Variance Parameters to Incorporate Uncertainty into Health Economics Models Following Treatment Switching

    Nov 1, 2016, 00:00

  • Adapting Data Sources for Systematic Literature Review Retrieves Additional Data Relevant for Asian HTA

    Nov 1, 2016, 00:00

  • The Cost Of Relapse Remitting Multiple Sclerosis Disease - Patient Reported Study In Egypt

    Nov 1, 2016, 00:00

  • Strategic Considerations to Engage in Early Advice with European Health Technology Assessment Bodies

    Nov 1, 2016, 00:00

  • Parallel Export And Its Impact On Availability Of Drugs In Slovakia

    Nov 1, 2016, 00:00

  • Assessing Primary Care Practice Capacity For Quality Improvement- Preliminary Findings From Healthy Hearts in The Heartland (H3)

    Nov 1, 2016, 00:00

  • Economic Burden of Schizophrenia in China- A Literature Review

    Nov 1, 2016, 00:00

  • Adoption of Oncology Biosimilars in Europe

    Nov 1, 2016, 00:00

  • A Unique Opportunity To Assess Quality-Of-Life Changes In Long-Term Waitlisted Bariatric Surgery Patients Using The Eq-5d-5l And Aqol-8d Multi-Attribute Utility Instruments Before And Three Months After Bariatric Surgery- An Exploratory Stu ...

    Nov 1, 2016, 00:00

  • Equity of Government Subsidy in Health Care- A Case Study in China

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Sq® Hdm Slit-Tablet For House Dust Mite Respiratory Allergic Disease In Czech Republic

    Nov 1, 2016, 00:00

  • Receipt and Delivery of Medication Risk and Safety Information- Perceptions of Consumers and Healthcare Professionals (HCPS) in the US

    Nov 1, 2016, 00:00

  • EQ-5D Studies in Rheumatology in Eight Central and Eastern European Countries

    Nov 1, 2016, 00:00

  • Project Octo-Pills- Management Of Polypharmacy And Drug Related Problems From Hospital To Community Pharmacies – An Octopus Initiative For The Silver Tsunami

    Nov 1, 2016, 00:00

  • Incidence and Risk Factors of Glucocorticoid-Induced Diabetes Mellitus in Lymphoma Patients Treated with Glucocorticoid-Containing Chemotherapy

    Nov 1, 2016, 00:00

  • Japan Health Care Act Reform- Toward Decentralization And Integrated Health Care System

    Nov 1, 2016, 00:00

  • Quality of Life in Patients with Colorectal Cancer in Slovak Republic

    Nov 1, 2016, 00:00

  • Patient Reported Asthma Control In Comparison To Physician Assessed Asthma Control- A Cross-Sectional Analysis of The Act Questionnaire Based on 673 Asthma Patients

    Nov 1, 2016, 00:00

  • HCV- Estimation of the Number of Diagnosed Patients Eligible to New Anti-HCV Therapies in Italy

    Nov 1, 2016, 00:00

  • Adherence To Gold Criteria Strategy In Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients- Cost Implications In Turkey

    Nov 1, 2016, 00:00

  • Approach to Implementation of a Feasible Antibiotic Stewardship Program at a Tertiary University Public Hospital

    Nov 1, 2016, 00:00

  • Comparing The EQ-5D-5L Value Sets Across Diferent Countries – Impact on Inpertretation of Clinical Study Results

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Empagliflozin in Patients with T2DM and High CV Risk in Canada

    Nov 1, 2016, 00:00

  • Early HTA in Pharmacogenomics- A Case Example in Cardiovascular Drugs

    Nov 1, 2016, 00:00

  • Investigating The Economic Impact of Sflt-1/PLGF Ratio As A Predictive Test in Women with Suspected Preeclampsia in Italy

    Nov 1, 2016, 00:00

  • Analysis of The Costs Associated with Vitamin K Antagonist Treatment for Stroke Prevention in Non Valvular Atrial Fibrialltion in Mexico

    Nov 1, 2016, 00:00

  • Linear, Flat And Mixed Pricing Structures As Negotiation Quantities Of New Medicinal Products In Context Of Amnog In Germany- A Comparison At Market Launch And Post Price Negotiations

    Nov 1, 2016, 00:00

  • Exploring Bias in Meta-Analysis Due to Competing Risks and Different Data Types, with Application to Stroke Prevention in Atrial Fibrillation

    Nov 1, 2016, 00:00

  • The Role of Insulin-Like Growth Factor-1 on Steatohepatitis

    Nov 1, 2016, 00:00

  • Beyond Cervical Cancer- The Cost-Effectiveness Of Hpv Vaccination In The Netherlands

    Nov 1, 2016, 00:00

  • Alcoholism In Italy- An Introductive Analysis of Consumption And Hospitalisation Trends

    Nov 1, 2016, 00:00

  • Current and Preferred Status on HTA Implementation- A Ukrainian Perspective

    Nov 1, 2016, 00:00

  • Pharmaceutical Industry\X92S Experiences With The Scientific Advice Offered By The Federal Joint Committee Within The Early Benefit Assessment Of Drugs In Germany

    Nov 1, 2016, 00:00

  • Validity Of The Eq-5d-Youth In Asthmatic Children

    Nov 1, 2016, 00:00

  • Hepatitis C Treatment with First-Generation Protease Inhibitors in A Real-World Cohort- Risk-Benefit Profile and Costs of the Therapy

    Nov 1, 2016, 00:00

  • Health Insurance Cost Of Multiple Sclerosis In Hungary- A Cost Of Illness Study

    Nov 1, 2016, 00:00

  • The Impact of Medical Insurance Coverage of Imatinib and Molecular Monitoring Frequency on Outcomes in Treatment of Chronic Myeloid Leukaemia (CML)- A Real World Evidence in China

    Nov 1, 2016, 00:00

  • A Comparison of National Guidelines for Network Meta Analysis

    Nov 1, 2016, 00:00

  • Determination Of The Vaccine-Preventable Diseases Burden In Turkey In Terms Of Various Vaccination Policies

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Xpert MTB/RIF Assay for Diagnosing Tuberculosis in Malaysia Using Dynamic Transmission Model

    Nov 1, 2016, 00:00

  • Burden of Metastatic Castration-Resistant Prostate Cancer (MCRPC) in Turkey

    Nov 1, 2016, 00:00

  • Work and Income Loss Consideration Among Patients With Herpes Zoster When Completing A Quality Of Life Questionnaire

    Nov 1, 2016, 00:00

  • Epidemiological Characteristics Of Hospitalizations Due To Adverse Drug Reactions (Adrs) Relaed To Oral Anticoagulants In Spain- 2010-2013

    Nov 1, 2016, 00:00

  • Medical Care Costs of Diabetes Using an Instrumental Variable Approach

    Nov 1, 2016, 00:00

  • Different Methods, Different Results? Comparing Health Technology Assessments in the United Kingdom and Germany

    Nov 1, 2016, 00:00

  • Single-Arm Trials in Systematic Reviews- Are They Adequately Captured by Existing Search Filters?

    Nov 1, 2016, 00:00

  • Costs Associated with Treatment Induced Peripheral Neuropathy in Patients with Multiple Myeloma (MM)

    Nov 1, 2016, 00:00

  • Real-World Treatment Pattern in Community Patients with Type-2 Diabetes- Evidence from Shanghai, China

    Nov 1, 2016, 00:00

  • Added Benefit of Upper Airway Stimulation For The Treatment of Moderate To Severe Obstructive Sleep Apnea In Austria

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Dabigatran for The Prevention of Stroke in Iranian Atrial Fibrillation Patients

    Nov 1, 2016, 00:00

  • A Study on Identification, Monitoring and Management of Adverse Drug Reactions in a Tertiary Care Hospital

    Nov 1, 2016, 00:00

  • Surgical Site Complications- to Prevent or Not to Prevent? A Budget Impact Analysis in the Hospital Setting

    Nov 1, 2016, 00:00

  • PCSK9-Inhibitors- Identification of Eligible Patients from Regional Administrative Healthcare Databases

    Nov 1, 2016, 00:00

  • Estimating the Value of Treatment for Fabry Disease- A Discrete Choice Experiment

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of H. Pylori Eradication Treatment Regimens in Peptic Ulcer Disease in Ukraine

    Nov 1, 2016, 00:00

  • Current Status of Endoscopic Submucosal Dissection for Gastric Cancer Within Absolute Indication in Korea- Based on National Claims Database

    Nov 1, 2016, 00:00

  • Cost Implications Of Inappropriate Prescribing Of Anti-Malarial Therapy For Treatment Of Undifferentiated Febrile Illness Among Elderly

    Nov 1, 2016, 00:00

  • A Novel Method for Evaluating Value Assessment Frameworks

    Nov 1, 2016, 00:00

  • Castration-Resistant Prostate Cancer (CRPC)- Evaluation of The Quality of Care and Disease Management in Real-Life Setting

    Nov 1, 2016, 00:00

  • The Economic Burden of Pulmonary Embolism in Europe

    Nov 1, 2016, 00:00

  • Economic Evaluation Of Rfsh And Hp-Hmg For Infertility Treatment In Brazil

    Nov 1, 2016, 00:00

  • Rate and Healthcare Utilization (Los And Costs) of Adhesion Related Complications after Liver Resection Surgery

    Nov 1, 2016, 00:00

  • The Economic Burden of Multiple Sclerosis in Spain- A Population Based Study

    Nov 1, 2016, 00:00

  • Comparative Efficacy of Daratumumab Monotherapy and Pomalidomide Plus Low Dose Dexamethasone (POMA+LODEX) in The Treatment of Multiple Myeloma - A Matching Adjusted Indirect Comparison (MAIC)

    Nov 1, 2016, 00:00

  • Watch Out for Berkson's Bias (BB)! Setting Health-Related Quality of Life (HRQOL) Treatment Targets with Matching-Adjusted Indirect Comparison (MAIC) in Order to Predict Matched General Population Control (MGPC) Targets, Assess Potential to ...

    Nov 1, 2016, 00:00

  • Combined use of Administrative Data Flows with Innovative Biologic Drug Registries to Assess Therapeutic Appropriateness- An Italian Regional Experience

    Nov 1, 2016, 00:00

  • Economic Impact of Macular Edema Diseases in Italy

    Nov 1, 2016, 00:00

  • Issues Related to the Frequency of Exploratory Analyses by Evidence Review Groups in the Nice Single Technology Appraisal Process

    Nov 1, 2016, 00:00

  • Evaluating Effectiveness And Persistency of A Pharmacist-Led Disease Management Program

    Nov 1, 2016, 00:00

  • Future Innovative Therapies for Parkinson's Disease May Question Sustainability of Our Health Care System

    Nov 1, 2016, 00:00

  • A New Organizational Integrated Home-Care Model- An Italian Pilot Study

    Nov 1, 2016, 00:00

  • Differential Factors Predicting Major Adverse Cardiovascular Events In Atherosclerotic Patients with and without Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Identification and Management of Patients with Statin Intolerance in Saudi Arabia and the United Arab Emirates- Comparison of Results from a Clinician Survey

    Nov 1, 2016, 00:00

  • How Much are Chinese Willing to Pay for the Health Improvement?

    Nov 1, 2016, 00:00

  • Correlation Between Structural Damage and Work/Activity Impairment Among Rheumatoid Arthritis Patients

    Nov 1, 2016, 00:00

  • Current Situation and Prospect of Orphan Drugs in China

    Nov 1, 2016, 00:00

  • Movement of Drugs for Cancer Through The Pharmacoeconomic Evaluation Process in Ireland- Consideration Given to The Quality of Clinical Evidence

    Nov 1, 2016, 00:00

  • Developing Item Pools for Physical Functioning, Social Relationships, and Positive Mindset to Measure Health-Related Quality of Life (HRQOL) in the Singapore Population

    Nov 1, 2016, 00:00

  • Survival And Death Risk of Patients With Prostate Cancer Treated In The Brazilian Public Health System

    Nov 1, 2016, 00:00

  • Somatic Symptoms in Patients with Undiagnosed Depression- Prevalence and Health Care Utilization In Japan

    Nov 1, 2016, 00:00

  • Challenges for HTA Submissions Concerning Conditions Lacking Established Treatment Pathways

    Nov 1, 2016, 00:00

  • Comparision Of Perception Towrds Generic Medicines Between Final Year Pharmacy And Medical Students In Southeast Yemen

    Nov 1, 2016, 00:00

  • Treatment Patterns of Rheumatoid Arthritis in Japanese Hospitals and Predictors of Initiation Biologic Agents

    Nov 1, 2016, 00:00

  • Assessment Of Regional Legislation Related To The Use Of Similar Biological Medicinal Products- The Italian Case Study

    Nov 1, 2016, 00:00

  • Early Benefit Assessment Of Drugs And The Value-Based Healthcare Concept – A Qualitative Inquiry Within The Pharmaceutical Industry

    Nov 1, 2016, 00:00

  • Development of A Global Model For The Economic Evaluation of A Biomarker For The Treatment of Uncontrolled Moderate To Severe Asthma

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Caspofungin Versus Voriconazole in the Empirical Antifungal Therapy of Febrile Neutropenia in China

    Nov 1, 2016, 00:00

  • Estimating the Value of A New Antibiotic- A Novel Approach Using Esbl As A Case Study

    Nov 1, 2016, 00:00

  • Success and Failure of Straightforward Versus Sophisticated Managed Entry Agreements

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Pembrolizumab vs. Docetaxel for Treatment of Previously Treated PD-l1 Positive Advanced NSCLC Patients

    Nov 1, 2016, 00:00

  • Comparison of Trend, Outcome, and Cost of open, Laparoscopic, and Robotic Surgical Treatment for Colorectal Cancer- A Propensity Score Matched Analysis of A National Database

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Roflumilast As Add-On To Triple Inhaled Therapy Vs Triple Inhaled Therapy In Patients with Severe And Very Severe COPD Associated with Chronic Bronchitis In Sweden

    Nov 1, 2016, 00:00

  • A Systematic Review Of Economic Evaluation Alongside Hematopoietic Stem Cell Transplantation In Japan

    Nov 1, 2016, 00:00

  • The Cost of Post Stroke Treatment at Selected Public Primary Care Healthcentres In Malaysia

    Nov 1, 2016, 00:00

  • Different Values In Cost-Effectiveness Research- Institute for Clinical and Economic Review (ICER) VS. The National Institute for Care Excellence (NICE)

    Nov 1, 2016, 00:00

  • Non-Adherent Behaviour and Glycaemic Control in Patients with Type 2 Diabetes Treated with Insulin

    Nov 1, 2016, 00:00

  • Protective Effect of Metformin Against Tuberculosis in Diabetic Patients

    Nov 1, 2016, 00:00

  • Should Patients Estimate Health Related Quality Of Life? The Results Of Empirical Study

    Nov 1, 2016, 00:00

  • Using A Discrete Choice Experiment To Value Informal Care Provided To Children with Intellectual Disabilities

    Nov 1, 2016, 00:00

  • The Impact of Country-Specific Utility Tariffs on the Outcome of Cost-Utility Analyses; A Case Study

    Nov 1, 2016, 00:00

  • Reimbursement of Insulin for Diabetes- Implementation from the Ukrainian Health Care Perspective

    Nov 1, 2016, 00:00

  • Development of the Musculoskeletal Health Questionnaire (MSK-HQ) for Use in Different Conditions and Different Healthcare Pathways

    Nov 1, 2016, 00:00

  • Real World Utilization of Biological Agents in Rheumatoid Arthritis Patients- A French National Claims Database Analysis Over The Period 2010–2014

    Nov 1, 2016, 00:00

  • Health-Related Quality of Life for People with Chronic Lower Back Pain- Results from a Large, Prospective, Random-Select, Open-Labelled and Blinded End-Point Study, Analysed by Response to Treatment

    Nov 1, 2016, 00:00

  • The Frequency of Relapsed or Refractory Disease After Autologous Stem Cell Transplantation in Classical Hodgkin Lymphoma- A Systematic Review

    Nov 1, 2016, 00:00

  • Treatment Switching Problem in Cancer Clinical Trials – Implications for Health Technology Appraisal Outcomes

    Nov 1, 2016, 00:00

  • Predictors of 1 Year Mortality in Patients with Contralateral HIP Fracture After Femoral Neck Fracture

    Nov 1, 2016, 00:00

  • Vaginal Birth After Caesarean Versus Elective Repeat Caesarean Delivery In Four European Countries- A Cost-Utility Analysis

    Nov 1, 2016, 00:00

  • Nintedanib Cost-Utility In Idiopathic Pulmonary Fibrosis In France

    Nov 1, 2016, 00:00

  • Trend Of Antidepressant Utilization In Iran, 2006- 2015

    Nov 1, 2016, 00:00

  • The Relationship Between Medical Innovation And Health Expenditures

    Nov 1, 2016, 00:00

  • Examining The Relationship Between Suicidal Ideation, Depression and Selected Chronic Diseases Using The Nhanes Dataset

    Nov 1, 2016, 00:00

  • The Impact Of Increasing Disability On Employment And Caregiver Burden Among Multiple Sclerosis Patients In Brazil

    Nov 1, 2016, 00:00

  • Influence of Medical Representatives on Prescribing Practices in Mekelle, Northern Ethiopia

    Nov 1, 2016, 00:00

  • Review of Health Economic Models for Antibiotics

    Nov 1, 2016, 00:00

  • Government Sponsored Health Insurance Schemes for Reimbursement of Cancer Treatment in India

    Nov 1, 2016, 00:00

  • Patient-Relevant Endpoints In Psoriasis – A Literature Review Of Patient Preference Studies

    Nov 1, 2016, 00:00

  • A Systematic Review on the Evidence of Adequate Discount Rates for Vaccines in Germany

    Nov 1, 2016, 00:00

  • Uptake of Hepatitis B HIV Co-Infection Screening And Management In A Resource Limited Setting

    Nov 1, 2016, 00:00

  • Comparing of Osteoplastic Biomaterials In The Operation of Regeneration of Alveolar Bone

    Nov 1, 2016, 00:00

  • Eliciting Individual Patient Preferences on The Benefits and Risks of Cancer Treatments- Results From A Survey Conducted in Myeloma Patients

    Nov 1, 2016, 00:00

  • A Study Evaluating Living Organ Donors In Kidney And Liver Transplantation

    Nov 1, 2016, 00:00

  • A Review of Treatment on Alzheimer's Disease in China

    Nov 1, 2016, 00:00

  • Utilisation Of Survival Outcomes Data To Forecast Economic Impact Of Pricing And Market Access Scenarios In A Multi-Indication Patient Flow Models

    Nov 1, 2016, 00:00

  • Assessment Of Knowledge, Attitude And Practice (Kap) Of Pharmacist Regarding Adverse Drug Reaction (Adrs) And Pharmacovigilance In Public Hospitals Quetta

    Nov 1, 2016, 00:00

  • Relations between Adherence to Therapy and Quality of Life (Qol) In Cml Patients in Bulgaria

    Nov 1, 2016, 00:00

  • Cost Minimization Analysis of Bevacizumab Versus Cetuximab and Panitumumab in the Management of Colorectal Cancer from Patient Perspective in Egypt

    Nov 1, 2016, 00:00

  • Healthcare Resource Consumption and Cost of Care in Patients with Autosomal Dominant Polycystic Disease (ADPKD) in Italy – Final Study Results

    Nov 1, 2016, 00:00

  • Real World use of Biologics Therpies for Patients with Ulcerative Colitis in Japan

    Nov 1, 2016, 00:00

  • Assessment of Awareness and Knowledge of Breast Cancer in Pakistani Females; A Quantitative Study

    Nov 1, 2016, 00:00

  • Cost Assessment for Healthy Diet in the State of Penang, Malaysia

    Nov 1, 2016, 00:00

  • Psychological Distress In Chinese Patients With Rheumatoid Arthritis And Psychometric Validation Of Chinese Hospital Anxiety And Depression Scale

    Nov 1, 2016, 00:00

  • A Health Policy Study Measuring The Gap Analysis Between The Management of Metastatic Conditions and Other Diseases Under The Egyptian Healthcare Insurance System

    Nov 1, 2016, 00:00

  • A Review of Studies of Health-Related Quality of Life Performed in Chinese-Speaking Ischemic Heart Disease Patients

    Nov 1, 2016, 00:00

  • A Study of the Successful Adaptation of the Quality of Life Questionnaire - Bronchiectasis From Paper To Electronic Format

    Nov 1, 2016, 00:00

  • Inhaled Iloprost Therapy and Pulmonary Arterial Hypertension- Experience in a Formulary Decision Study

    Nov 1, 2016, 00:00

  • Dice Simulation- A New Method that Facilitates Decision-Analytic Modeling

    Nov 1, 2016, 00:00

  • Cancer Prevention- Knowledge And Attitudes Among Healthcare Professionals

    Nov 1, 2016, 00:00

  • The Economic Burden Of Chronic Obstructive Pulmonary Disease In China- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Chronic Patients Attitudes, Beliefs, and Experiences Regarding Polypharmacy and Willingness to Deprescribein Quetta

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Secukinumab as First Biologic Treatment for Psoriasis Compared with Initiating Other Biologic Therapy in Germany

    Nov 1, 2016, 00:00

  • Administrative Claims Analysis of All-Cause Healthcare Resource Utilization for T2DM with Chronic Comorbidities Patients in China

    Nov 1, 2016, 00:00

  • Results of HTA in Brazil- The Performance of Conitec in its First Five Years

    Nov 1, 2016, 00:00

  • A Calculating Analysis Model on Disability Adjusted of Life Years Among Patients Suffering from Alzheimer's- Based on The Improvement of Multi-State Markov Model

    Nov 1, 2016, 00:00

  • Public Consultation as a Tool for Patient and Public Involvement in The Brazilian HTA Process

    Nov 1, 2016, 00:00

  • Insights from 6 Years' Managed Entry Agreement Experience in Belgium

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Brentuximab Vedotin in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma in Taiwan

    Nov 1, 2016, 00:00

  • Psychometric Validation of the Pulmonary Arterial Hypertension Symptoms and Impact (PAH-SYMPACT®) Questionnaire

    Nov 1, 2016, 00:00

  • Intravenous (IV) Admnistration of Morphine For Moderate-To-Severe Acute Pain In The Emergency Room (ER) Setting Inflicts A Substantial Economic Burden In The EU5

    Nov 1, 2016, 00:00

  • Measurement Properties of The EQ-5D-5l Compared To The EQ-5D-3L In Psoriasis Patients

    Nov 1, 2016, 00:00

  • Info-Diabetic Approach from Cellular Phone Text Massaging can Minimize the Complexities in Diabetic Patient Care

    Nov 1, 2016, 00:00

  • Advanced Soft Tissue Sarcoma- Systemic Treatment Patterns and Survival in Germany

    Nov 1, 2016, 00:00

  • Prevalence, Potential Risk Factors, Sequelae of Diastasis Recti Abdominis and The Treatment

    Nov 1, 2016, 00:00

  • Comparison of German, French and Polish Utility Weights for The Eortc Utility Instrument QLU-C10D

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Cyp2c19*2 Genotype Guided Selection of Clopidogrel or Ticagrelor in Hong Kong Chinese Patients with Acute Coronary Syndrome

    Nov 1, 2016, 00:00

  • How can healthcare pathways explain polypharmacy in france? A longitudinal analysis between 2011 and 2014

    Nov 1, 2016, 00:00

  • Accuracy Of Text Processing Tokenisers For Automated Identification Of Diseases And Interventions In Abstracts Of Studies On Humanistic And Economic Burden Of Disease

    Nov 1, 2016, 00:00

  • Nine Tests For Assesing Validity Of A Discrete-Choice Experiment

    Nov 1, 2016, 00:00

  • Implemantation of Processes to Estabilishing a HTA Unit in Czech Hospital Enviroment

    Nov 1, 2016, 00:00

  • Real-World Hospitalisation and Mortality of Incident and Prevalent Patients with Heart Failure Due to Left Ventricular Systolic Dysfunction in England

    Nov 1, 2016, 00:00

  • Budget Impact Model to Augment The Value of An Innovative Device for The Early Detection of Pressure Ulcers in Scotland

    Nov 1, 2016, 00:00

  • Budget Impact Analysis Of Olaparib Use in Patients Brca – Mutated Psroc in Greece

    Nov 1, 2016, 00:00

  • Analysis of Patients' Satisfaction on the Implementation of Essential Drug System in China

    Nov 1, 2016, 00:00

  • A Modeled Health Economic Analysis of the Accucath® Intravenous Catheter System with Retractable Coiled Tip Guidewire Compared with Conventional Peripheral Intravenous Catheters

    Nov 1, 2016, 00:00

  • Adherence to Drug-Related Monitoring Guidelines for Multiple Sclerosis Therapies- Real-World Evidence From A Us Claims Database

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of The 13-Valent Pneumococcal Conjugate Vaccine In Adults In Portugal

    Nov 1, 2016, 00:00

  • Knowledge, Attitude and Perception of the General Public Regarding Polio and its Vaccination in Khyber Pakhtunkhwa, Pakistan. a Qualitative Study

    Nov 1, 2016, 00:00

  • Causes of Death Statistics Underestimate the Burden of Head and Neck (HN) Cancers- A Nationwide Study From France in 2008-2012 (Epicorl Study)

    Nov 1, 2016, 00:00

  • Managed Access Agreements- A New Model Pathway for The Reimbursement of Non-Oncology Drugs in England Approved Under European Adaptive Pathways?

    Nov 1, 2016, 00:00

  • The Stool Antigen Test For Detection of Helicobacter Pylori For Diagnose H.Pylori Infection And Assessment of Eradication Therapy

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Cosyrel for The Treatment of Hypertension in Italy

    Nov 1, 2016, 00:00

  • Azacitidine For The Treatment of Adult Patients (Age 65 or Older) with Acute Myeloid Leukemia And >30% Bone Marrow Blasts In Spain- Budget Impact Analysis

    Nov 1, 2016, 00:00

  • Health Related Quality of Life of Hidradenitis Suppurativa Patients in Finland

    Nov 1, 2016, 00:00

  • Integration of HIV Aids Program Intervention into Universal Health Coverage (UHC) - Lesson Learned from Indonesia

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Solifenacin for The Treatment of Overactive Bladder From A Us Private Payer and Medicare Advantage Perspective

    Nov 1, 2016, 00:00

  • Managing Healthcare Resources- Estimated Budget Impact On The National Health Service (England) Of Introduction Of Antimicrobial Sutures

    Nov 1, 2016, 00:00

  • Nationwide Survey on The Opinions of Cancer Patients and Personnel on Cost of Metastatic Colorectal Cancer Treatment

    Nov 1, 2016, 00:00

  • Using Geographical Information Systems To Describe Quality Of Life As A Function Of Distance In Cancer Patients

    Nov 1, 2016, 00:00

  • Measurement of Adherence To Anti-Hypertensive Drugs in Asia

    Nov 1, 2016, 00:00

  • Evaluation of The Cost Saving Potential of Introducing Benepali®, An Etanercept Biosimilar, For The Treatment of All Licensed Adult Etanercept Indications In Four Regions In Germany

    Nov 1, 2016, 00:00

  • Estimating The Cost of End-Stage Renal Disease to The Hospital System in SingaporeSidharta SD*1, Yang F2, Yoong JS1

    Nov 1, 2016, 00:00

  • Understanding the Relationship Between Effectiveness and Outcome Indicators in Health Care

    Nov 1, 2016, 00:00

  • Regional Market Access Pathways for Diagnostics in Italy

    Nov 1, 2016, 00:00

  • Systematic Review Toolbox

    Nov 1, 2016, 00:00

  • Low-Density Lipoprotein Cholesterol Lowering Efficacy of Evolocumab May Reduce Need for Apheresis in Heterozygous Familial Hypercholesterolaemia Patients According to Russian Guidelines

    Nov 1, 2016, 00:00

  • Cost Per Responder Analysis of Sucrofferric Oxhydroxide Versus Sevelamer Carbonate in Patients on Hemodialysis in Europe

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Combination Therapy with Dutasteride/Tamsulosin- An Analysis Based on Conduct Trial

    Nov 1, 2016, 00:00

  • Estimating the Economic Burden Associated with The Early Stages of Progression of Alzheimer’s Disease in Europe

    Nov 1, 2016, 00:00

  • Legislative Framework for Reimbursement Conditions for Gene Therapies

    Nov 1, 2016, 00:00

  • Health-Related Quality of Life in Systemic Sclerosis- Feasibility and Construct Validity of Eq-5d

    Nov 1, 2016, 00:00

  • Are Component Endpoints Equal? A Study into the Practice of Composite End Points in Clinical Trials

    Nov 1, 2016, 00:00

  • Stable Multiple Sclerosis Patients on an Interferon Therapy Have Better Outcomes When Staying on Therapy than Patients who Switch to Another Interferon

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Aclidinium Bromide In The Treatment of Chronic Obstructive Pulmonary Disease

    Nov 1, 2016, 00:00

  • Comorbidity of Depression And Type 2 Diabetes- A Retrospective Japanese Claims Database Analysis

    Nov 1, 2016, 00:00

  • Man Versus Machine - Is Accurate Automation of Data Abstraction Achievable?

    Nov 1, 2016, 00:00

  • Tax Losses and Gains Attributed to Smoking Cessation in Korea

    Nov 1, 2016, 00:00

  • Cost of Treatment Hypertention Inpatients in Vietnam

    Nov 1, 2016, 00:00

  • Health-Related Quality of Life of Users of Primary Care in Brazil

    Nov 1, 2016, 00:00

  • Adaptive Reimbursement Model- How to Correlate The Price to The Level of Evidences During The Entire Drug Life Cycle

    Nov 1, 2016, 00:00

  • The Pricing and Reimbursement of Specialty Drugs in Key Asian Markets

    Nov 1, 2016, 00:00

  • Preferences For Treatment Attributes Of Dulaglutide And Liraglutide Among Patients With Type 2 Diabetes Mellitus And Their Willingness To Self-Inject Diabetes Medication- A Comparison Between Japan And The United Kingdom

    Nov 1, 2016, 00:00

  • The Prevalence of Nosocomial Infections in Karaganda (Kazakhstan) During 2011-2015

    Nov 1, 2016, 00:00

  • Recent Trends in Percutaneous Coronary Intervention Volume in the United States

    Nov 1, 2016, 00:00

  • Investigating The Cost-Effectiveness of Genetic Counselling for Couples At Known Risk of Having Children with Tay-Sachs Disease- A Two-Generation Model

    Nov 1, 2016, 00:00

  • Psychometric Evaluation of Clinical Outcomes Assessments in A Phase II Trial

    Nov 1, 2016, 00:00

  • Improvements in Productivity at Paid Work and Within the Household, and Increased Participation in Daily Activities Over 52 Weeks of Certolizumab Pegol Treatment of Rheumatoid Arthritis- Results of A Belgian Observational Non-Interventional ...

    Nov 1, 2016, 00:00

  • Characteristics and Quality of Life in Peripheral Arterial Disease(Pad) Patients In Korea- Results From Pad Outcomes Research

    Nov 1, 2016, 00:00

  • Health Risk Of Drugs And Its Impact On Patient Adherence To Medical Treatment

    Nov 1, 2016, 00:00

  • Overview of the Budget Impact Analysis of Drugs in Hungary and Internationally

    Nov 1, 2016, 00:00

  • The Clinical And Pharmacoeconomic Challenges For Securing Reimbursement And Access To Cdx In The Eu

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Dasatinib in Imatinib-Resistant Or-Intolerant Patients with Chronic Phase Chronic Myeloid Leukemia (Cml-Cp) in the Chinese Setting

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of First-Line Gefitinib, Erlotinib and Afatinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR Mutations

    Nov 1, 2016, 00:00

  • Baseline Characteristics and Survival of Patients Diagnosed with Advanced NSCLC in Sweden Between 2006 and 2013, Matched (1-4) To A Comparison Cohort From The General Population

    Nov 1, 2016, 00:00

  • Using Advanced Modeling To Identify The Factor Structure of The Improved Health Activities Questionnaire

    Nov 1, 2016, 00:00

  • Description of the Impact of Hypertension on Hospitalisations for Cardiovascular Diseases in Japan Using a Japanese Claims Database

    Nov 1, 2016, 00:00

  • Application of Multi-Criteria Decision Analysis (Mcda) Scoring as an Hta Methodology for off-Patent Pharmaceuticals (Opp) in Emerging Markets

    Nov 1, 2016, 00:00

  • Comparative Safety and Effectiveness of Telemonitoring Intervention Versus Usual Care for Heart Failure- A Systematic Review and Meta-Analysis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Improved Influenza Vaccination Coverage in Adults Aged 60 Years and Older in Beijing, China

    Nov 1, 2016, 00:00

  • Improvement of Long Term Risks of Cardiovascular Events Associated with Community Based Disease Management in Chinese Patients of the Xin Jiang Autonomous Region of China

    Nov 1, 2016, 00:00

  • Incidence And Prevalence of Multiple Myeloma From 2016 To 2020 According To The Treatment Line And Hematopoietic Stem Cell Transplantation Status

    Nov 1, 2016, 00:00

  • A New Model to Identify Multivariate Causes of High Cost in Patient With Advanced Liver Disease

    Nov 1, 2016, 00:00

  • Cost Comparison in the Management of Adult Patients with Advanced Soft Tissue Sarcoma Previously Treated in Spain- Pazopanib vs. Trabectedina

    Nov 1, 2016, 00:00

  • Possible Explanations as to Why Effective Products Still Don't Have a Price in France

    Nov 1, 2016, 00:00

  • Is External Reference Pricing A Threat to International Equal Affordability?

    Nov 1, 2016, 00:00

  • Findings of a Literature Review in Support of a Patient Count Model (PCM) for Hepatitis C Virus (HCV) in the EU5

    Nov 1, 2016, 00:00

  • Cost of Type 2 Diabetes in Urban Indian Population

    Nov 1, 2016, 00:00

  • Patient Characteristics and Clinical Outcomes of Patients with Liver Cancer in a Tertiary-Care Hospital in Malaysia

    Nov 1, 2016, 00:00

  • Innovative Contracting- Evolving use of Web-Based Managed Entry Agreements in Italy

    Nov 1, 2016, 00:00

  • Novel Oral Anticoagulants in the UK and Fran Comparative Assessment of Costs of Prescriptions Dispensed in the Non-Hospital Setting

    Nov 1, 2016, 00:00

  • Impact of Trial Design on Price Discounts after Early Benefit Assessment (AMNOG) in Germany

    Nov 1, 2016, 00:00

  • Knowledge, Attitude and Practice (KAP) Regarding Blood Donation Among Health Care Workers in Malaysia

    Nov 1, 2016, 00:00

  • Estimation of National Economic Burden of Hypoglycaemia Among Type 2 Diabetes Mellitus Patients in Malaysia

    Nov 1, 2016, 00:00

  • The Ethical Issues Of Pharmacogenetic Tests

    Nov 1, 2016, 00:00

  • Cost Analysis Of Comorbities- Evidence From A Hiv+ Patients Cohort

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Cancer Risk Reduction Strategies for BRCA Mutation Carriers

    Nov 1, 2016, 00:00

  • Impact of Adherence on Subcutaneous Interferon Beta-1a Effectiveness Administered by Rebismart® in Patients with Multiple Sclerosis

    Nov 1, 2016, 00:00

  • Risk Factors of Cardiovascular Disease in Malaysian Diabetes Patients

    Nov 1, 2016, 00:00

  • Why Should We Focus on A Structured Model of Secure Digital Exchanges To Incorporate New Documents In Electronic Patient Records?

    Nov 1, 2016, 00:00

  • An Assessment Of Biosimilars’ Behaviour In The Eu-5 Countries

    Nov 1, 2016, 00:00

  • Characteristics and Outcomes of Patients with Hospital-Acquired Pneumonia (Hap)

    Nov 1, 2016, 00:00

  • Metastatic Colorectal Cancer In Croatia - Cost of Disease Study

    Nov 1, 2016, 00:00

  • Cost Efectivness of Darbepoetin Alfa Versus Epoetin Alfa In The Management of Anemic Patients With Chronic Kidney Disease-Health Insurance Perspective

    Nov 1, 2016, 00:00

  • Empirical Calibration of Hepatitis C Virus (HCV) Natural History Model to the Chinese HCV-Infected Population

    Nov 1, 2016, 00:00

  • The Economic Burden of Four Heart Conditions in Mexico

    Nov 1, 2016, 00:00

  • The Sale of Antibiotics Without Prescription In Retail Pharmacies- A Cross-Sectional Survey In Three Cities of China

    Nov 1, 2016, 00:00

  • Three-Monthly Long-Acting Antipsychotic Therapy Results in A Better Treatment Continuity Compared to A One-Monthly or Bi-Weekly Treatment In Schizophrenia

    Nov 1, 2016, 00:00

  • A Comprehensive Economic Model for Dementia- Diagnosis, Disease Progression and Service Delivery

    Nov 1, 2016, 00:00

  • Prescribing Pattern of Anti Hypertensive Agents in A Tertiary Care Hospital Outpatient Department

    Nov 1, 2016, 00:00

  • Evaluation of Injectable Lanreotide Acetate in The Treatment of Liver Carcinoma

    Nov 1, 2016, 00:00

  • The Cost Effectiveness of Tumour Necrosis Factor-α Inhibitors For Ankylosing Spondylitis And Non-Radiographic Axial Spondyloarthritis

    Nov 1, 2016, 00:00

  • Landscape of Advanced NSCLC- The Impact of Upcoming Therapies

    Nov 1, 2016, 00:00

  • Jointly Modeling Survival and EQ-5D Data to Estimate Health Utilities for Her2+ Metastatic Gastric Cancer

    Nov 1, 2016, 00:00

  • Recent Trends In Different Devices, Operating Systems, And Browsers Used By Patients Taking Part In Online Medical Surveys

    Nov 1, 2016, 00:00

  • Drug Utilizaton and Pharmacoeconomic Analysis of Geriatric Patients in a Tertiary Care Teaching Hospital

    Nov 1, 2016, 00:00

  • Economic Burden of Community-Acquired Pneumonia Among Elderly

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Pembrolizumab for Treating Previously Untreated Metastatic Melanoma Patients in France

    Nov 1, 2016, 00:00

  • Recommendations for the Calculation of Transition Probabilities in Markov Cohort Models- A Targeted Literature Review

    Nov 1, 2016, 00:00

  • A Comparison Of Health State Utilities Among Breast Cancer Patients In Mainland China

    Nov 1, 2016, 00:00

  • Pharmacoeconomics Analysis of ACEI and ARB Against Essential Hypertension- A Case Study of Shanghai

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Analysis of Abiraterone Used for Metastatic Castrate-Resistant Prostate Cancer Before Chemotherapy

    Nov 1, 2016, 00:00

  • Clinical Outcomes of Bipolar Disorder on Long-Term Treatment with Lithium with or without Mood Stabilizers

    Nov 1, 2016, 00:00

  • Quality of Life in Advanced Melanoma- Results of The Dutch Melanoma Treatment Registry

    Nov 1, 2016, 00:00

  • Economic Impact of Olaparib in Patients with Platinum Sensitive Relapsed Brca Mutated Epithelial Ovarian Cancer in Spain

    Nov 1, 2016, 00:00

  • Budget Impact of Etanercept Biosimilars In The Treatment of Rheumatoid Arthrisis- An Analysis Based on French National Claims Database

    Nov 1, 2016, 00:00

  • A Systematic Review and Meta-Analysis on Tolerability and Efficacy of Sofosbuvir Containing Regimens in Hepatitis C Patients With Stage 4-5 Chronic Kidney Disease

    Nov 1, 2016, 00:00

  • A Real-World Outcome Research Study On Quality of Life, Work Productivity And Healthcare Resource Utilization In Metastatic Breast Cancer For Patients And Caregivers

    Nov 1, 2016, 00:00

  • Costs And Outcomes Of Hospital Infections In Italy

    Nov 1, 2016, 00:00

  • Budget Impact of Continuous Subcutaneous Insulin Infusion Compared with Multiple Daily Insulin Injections for The Treatment of Type 1 Diabetes in Spain

    Nov 1, 2016, 00:00

  • Eliciting Payers Preferences In Central And Eastern Europe- Results Of Mcda Case Study

    Nov 1, 2016, 00:00

  • Table of Contents

    Nov 1, 2016, 00:00

  • Does Real World Evidence Support Conclusions From Experimental Evidence In Decision-Making Processes In Poland?

    Nov 1, 2016, 00:00

  • Eliciting Stated Preferences Regarding Life Extensions Near the End of Life- A Pilot Study for a Refinement of the Qaly

    Nov 1, 2016, 00:00

  • Hba1c Variability Predicts Short-Term Risk of Albuminuria In Patients with Type 2 Diabetes

    Nov 1, 2016, 00:00

  • "Why Can't I Just Use Google Translate?" A Study on the Effectiveness of Online Translation Tools in Translation of Coas

    Nov 1, 2016, 00:00

  • Prescription Patterns and Drugs Costs in Patients with Dementia - A Retrsopective Database Analysis

    Nov 1, 2016, 00:00

  • Analysis of Cardiovascular Disease Burden on The Insured Population of Units Directly Under Fujian Province

    Nov 1, 2016, 00:00

  • Association Between The Prices Of Orphan Drugs In Oncology And The Patient Population Sizes

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Sacubitril/Valsartan Versus Angiotensin-Converting-Enzyme Inhibitor for The Treatment of Heart Failure From Public Health Perspective in Chile

    Nov 1, 2016, 00:00

  • Acute Respiratory Distress Syndrome Profile at a Tertiary Care Teaching Hospital in South India

    Nov 1, 2016, 00:00

  • Self-Reported Client Satisfaction In The Primary Care Development Model Programme

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Pixantrone for the Third-/Fourth-Line Treatment of Aggressive Non-Hodgkin’s Lymphoma in Portugal

    Nov 1, 2016, 00:00

  • Opportunities For Pharmaceutical Companies To Successfully Launch Products In African Countries

    Nov 1, 2016, 00:00

  • Metastatic Colorectal Cancer- The Burden of Illness in The Uk and Ireland

    Nov 1, 2016, 00:00

  • Public Knowledge and Attitudes Towards Zika Virus and its Prevention in Malaysia

    Nov 1, 2016, 00:00

  • Evaluating The Economic Burden and Health Care Utilization Of Breast Cancer in The Us Medicare Population

    Nov 1, 2016, 00:00

  • Ebola Virus Disease and Its Management- A Review

    Nov 1, 2016, 00:00

  • A Retrospective Study of Healthcare Costs in Patients with end Stage Lung Cancer During The Last Six Months of their Life

    Nov 1, 2016, 00:00

  • Health Technology Assessment on Continuous And Intermittent Renal Replacement Therapies For Acute Kidney Injury In Adult Patients

    Nov 1, 2016, 00:00

  • An Investigation Into Open-Source Modelling In Health Economics- Opportunities And Challenges

    Nov 1, 2016, 00:00

  • Cyproterone/Ethinylestradiol Use and Indications in the Netherlands

    Nov 1, 2016, 00:00

  • Methods For The Design And Conduct Of Medical Record Reviews In Oncology

    Nov 1, 2016, 00:00

  • Cross-Validation of A 7-Item Clinical Decision Rule for Detecting Panic-Related Anxiety in Emergency Medicine Patients

    Nov 1, 2016, 00:00

  • Cost Analysis of Intrathecal Baclofen Therapy For The Treatment of Spastic Cerebral Palsy In The Russian Federation

    Nov 1, 2016, 00:00

  • A Study on Evaluation of Effects of Anti-Tubercular Drugs on Hematological and Hepato-Renal Functions in Tuberculosis Patients

    Nov 1, 2016, 00:00

  • Recommendations In Clinical Guidelines, ‘No Benefit’ Ratings, And Opt-Out Decisions In Germany Since The Introduction Of The Amnog Law In 2011- How Do The Pieces Fit Together?

    Nov 1, 2016, 00:00

  • Assessing Quality Of Life Of Self-Reported Rheumatic Patients

    Nov 1, 2016, 00:00

  • Economic Evaluation of Tiotropium/Olodaterol Administrated Through The Respimat Inhaler As Maintenance Treatment of Patients With Chronic Obstructive Pulmonary Disease (COPD) In Poland

    Nov 1, 2016, 00:00

  • EU5 Patient's Willingness to Try New Techniques for Managing their Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Risk of Cardiovascuar Disease in Type 2 Diabetic Women on Sulfonylureas-A Retrospective Case-Control Study

    Nov 1, 2016, 00:00

  • Rosuvastatin- Switching Treatment and Clinical Implications in Primary Care

    Nov 1, 2016, 00:00

  • A Comparison of Long-Term Anticholinergic Burden Derived from Different Risk Scales with Adverse Clinical Outcomes in the Elderly

    Nov 1, 2016, 00:00

  • Application of Risk Adjusted Cost-Effectiveness Analyses for Stroke Treatment

    Nov 1, 2016, 00:00

  • Current Practice of Drug Treatment In Children with ILD- First Insights From The Child-Eu Registry

    Nov 1, 2016, 00:00

  • Economic Burden of Colorectal Resections- Incremental Effects in Cancer Patients

    Nov 1, 2016, 00:00

  • what Do we Pay for Compounded Drugs?

    Nov 1, 2016, 00:00

  • The Association Between Initiation of Guideline Recommended First-Line Systemic Therapy and Healthcare Costs and Utilization in a Metastatic Non-Small Cell Lung Cancer (MNSCLC ) Population

    Nov 1, 2016, 00:00

  • A Cost-Effectiveness Analysis of Biosimilar Infliximab (Inflectra®) For The Treatment of Psoriatic Arthritis In Nine European Countries

    Nov 1, 2016, 00:00

  • Economic Evaluation of ASA 100mg, Simvastatin 40mg and Ramipril 5-10mg (POLYPILL) for Secondary Prevention of Cardiovascular Events in Mexico

    Nov 1, 2016, 00:00

  • One-Year Patient-Reported Persistence To Antiresorptive Treatment In A Fracture Liaison Servi The Lucky Bone™ Program

    Nov 1, 2016, 00:00

  • Health Technology Assessments of Lama/Laba Combination Products

    Nov 1, 2016, 00:00

  • Comparison Study Based on Simulation of Patient Pathways Using Multi-State Models in Oncology

    Nov 1, 2016, 00:00

  • The Burden of Inflammatory Bowel Disease(IBD) in Japan

    Nov 1, 2016, 00:00

  • Development and Content Validity of the Advanced Systemic Mastocytosis Symptom Assessment Form (ADVSM-SAF)

    Nov 1, 2016, 00:00

  • Subclinical Hypothyroidism In Pediatric Population Treated With L-Thyroxine- A Retrospective Observational Analysis on 2001–2014 Administrative Data

    Nov 1, 2016, 00:00

  • Accuracy Of Natural Language Processing-Based Classifiers For Automated Identification Of Abstracts Of Studies On Humanistic And Economic Burden Of Disease

    Nov 1, 2016, 00:00

  • The Cost of Remaining NTM Positive- Health Care Utilization and Costs In A Sample of Patients with Refractory Pulmonary Disease Due To Mycobacterium Avium Complex In Canada, Germany, United Kingdom And France

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Transfemoral Aortic Valve Implantation Compared with Surgical Aortic Valve and Medical Management in Patients with Severe Symptomatic Aortic Stenosis in Australia

    Nov 1, 2016, 00:00

  • Changes In The Capacity Of Neurological And Psychiatric Inpatient Care In Hungary Between 1990 And 2014

    Nov 1, 2016, 00:00

  • Understanding Racial And Ethnic Differences In End of Life Care For Hospitalized Patients

    Nov 1, 2016, 00:00

  • A Comparative Analysis on Health Security System Between China and Developed Countries

    Nov 1, 2016, 00:00

  • All-Cause Mortality and Cardiovascular Events After Acute Myocardial Infarction and 12-Months Dual Platelet-Aggregation Inhibition in Clinical Practice. Findings from the Piper Study

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Dexamethasone Intravitreal Implant for Treatment of Diabetic Macular Oedema in Spain

    Nov 1, 2016, 00:00

  • An Exploration of Techniques for Addressing Uncertainty in Survival Estimates used Within Partitioned-Survival Models

    Nov 1, 2016, 00:00

  • The Effect of Diabetes on the Quality-of-Life in Community-Dwelling Elderly in The Netherlands

    Nov 1, 2016, 00:00

  • Defining Episodes of Care for Chronic Diseases- A Targeted Literature Review

    Nov 1, 2016, 00:00

  • Community Residents' Knowledge and Perceptions of Antibiotic Resistance in Penang, Malaysia- Findings and Implications

    Nov 1, 2016, 00:00

  • Clinical And Economic Analysis Of Two Surfactants For The Prevention And Treatment Of Respiratory Distress Syndrome

    Nov 1, 2016, 00:00

  • Predicting Patient-Reported Outcomes from Disease-Specific Questionnaires- A Comparison of Seven Methodologies

    Nov 1, 2016, 00:00

  • Economic and Humanistic Benefits of Maintaining Cognitive Impairment Patients in the Early Stage

    Nov 1, 2016, 00:00

  • The Economic Burden of Non-Tuberculous Mycobacterial Pulmonary Disease In Canada, France, United Kingdom And Germany

    Nov 1, 2016, 00:00

  • A CPRD-HES Database Study of Back Pain In The UK- Incidence And Prevalence

    Nov 1, 2016, 00:00

  • Italian Timings In New Drugs Approval- An Up-To-Date Analysis

    Nov 1, 2016, 00:00
  • «
  • 71
  • 72
  • 73
  • 74 (current)
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • »